Diabetes Technology & Therapeutics

Oral Semaglutide: A Review of the First Oral Glucagon-Like Peptide-1 Receptor Agonist.

Design and Clinical Evaluation of the Interoperable Artificial Pancreas System (iAPS) Smartphone App: Interoperable Components with Modular Design for Progressive Artificial Pancreas Research and Development.

Reviewing Connected Diabetes Care: The Newest Member of the Team.

A Prospective Multicenter Evaluation of the Accuracy and Safety of an Implanted Continuous Glucose Sensor: The PRECISION Study

An Intervention to Reduce Hypoglycemia Fear in Parents of Young Kids with Type 1 Diabetes via Video-Based Telemedicine (REDCHIP): Trial Design, Feasibility, and Acceptability.

Implementation of Basal–Bolus Therapy in Type 2 Diabetes: A Randomized Controlled Trial Comparing Bolus Insulin Delivery Using an Insulin Patch with an Insulin Pen

Early Initiation of Diabetes Devices Relates to Improved Glycemic Control in Children with Recent-Onset Type 1 Diabetes Mellitus.

Skin Problems Due to Treatment with Technology Are Associated with Increased Disease Burden Among Adults with Type 1 Diabetes.

Current Eligibility Requirements for CGM Coverage Are Harmful, Costly, and Unjustified

Documentation of skin-related issues associated with CGM use in the scientific literature.

High prevalence of skin reactions among pediatric patients with type 1 diabetes using new technologies: the alarming role of colophonium.

Human Factors Usability and Validation Studies of a Glucagon Autoinjector in a Simulated Severe Hypoglycemia Rescue Situation

Time Lag and Accuracy of Continuous Glucose Monitoring During High Intensity Interval Training in Adults with Type 1 Diabetes.

Differences for Percentage Times in Glycaemic Range Between Continuous Glucose Monitoring and Capillary Blood Glucose Monitoring in Adults with Type 1 Diabetes: Analysis of the REPLACE-BG Dataset.

Sotagliflozin Added to Optimized Insulin Therapy Leads to Lower Rates of Clinically Relevant Hypoglycemic Events at Any HbA1c at 52 Weeks in Adults with Type 1 Diabetes

Telemedicine-Assisted Self-Management Program for Type 2 Diabetes Patients.

Use of Telemedicine Technologies in Diabetes Prevention and Control in Resource-Constrained Settings: Lessons Learned from Emerging Economies

Changes in Accuracy of Continuous Glucose Monitoring Using Dexcom G4 Platinum Over the Course of Moderate Intensity Aerobic Exercise in Type 1 Diabetes.

Insulin Bolus Administration in Insulin Pump Therapy: Effect of Bolus Delivery Speed on Insulin Absorption from Subcutaneous Tissue.

GREATER SUPPRESSION OF GLUCAGON, LIPOLYSIS AND KETOGENESIS WITH INSULIN GLARGINE U300 AS COMPARED TO GLARGINE U100 IN TYPE 1 DIABETES MELLITUS.

Effectiveness and safety of physician versus patient-led titration of insulin glargine in Indian patients with type 2 diabetes mellitus: A sub-analysis of the Asian Treat to Target Lantus Study (ATLAS).

Development and Validation of PREDICT-DM: A New Microsimulation Model to Project and Evaluate Complications and Treatments of Type 2 Diabetes Mellitus.

EFFECT OF ADDING DAPAGLIFLOZIN AS AN ADJUNCT TO INSULIN ON URINARY ALBUMIN-TO-CREATININE RATIO OVER 52 WEEKS IN ADULTS WITH TYPE 1 DIABETES

Switching from suspend-before-low insulin pump technology to a hybrid closed loop system improves glucose control and reduces glucose variability: a retrospective observational case-control study.

Accuracy of FreeStyle Libre in adults with type 1 diabetes: the effect of sensor age.

Improvement in psychosocial outcomes in children with type 1 diabetes and their parents following subsidy for continuous glucose monitoring.

A Digital-First Model of Diabetes Care.

The Choice should be Yours: Diabetes-related Distress by Insulin Delivery Method for Patients with Type 1 Diabetes.

Safety and Tolerability of Insulin Aspart Biosimilar SAR341402 Versus Originator Insulin Aspart (NovoLog) When Used in Insulin Pumps in Adults with Type 1 Diabetes: A Randomized, Open-Label Clinical Trial

Efficacy and Safety of SGLT2 Inhibitors in Type 1 Diabetes After the Introduction of an Off-Label Use Protocol for Clinical Practice.

Efficacy and Safety of Tofogliflozin on 24-H Glucose Profile Based on Continuous Glucose Monitoring: Crossover Study of Sodium-Glucose Cotransporter 2 Inhibitor.

Storage Conditions of Insulin in Domestic Refrigerators and When Carried by Patients: Often Outside Recommended Temperature Range.

Effect of a Novel High Fiber Rice Diet on 24-Hour Glycemic Responses in Asian Indians Using Continuous Glucose Monitoring: A Randomized Clinical Trial.

Predicting Nocturnal Hypoglycemia with Measures of Physical Activity Intensity in Adolescent Athletes with Type 1 Diabetes.

Characteristics of Automated Insulin Suspension and Glucose Responses with the Predictive Low-Glucose Management System.

Demystifying the pizza bolus- the effect of dough fermentation on glycemic response - a sensor augmented pump intervention trial in children with type 1 diabetes mellitus.

Patient Values and Preferences Regarding Continuous Subcutaneous Insulin Infusion and Artificial Pancreas in Adults with Type 1 Diabetes: A Systematic Review of Quantitative and Qualitative Data.

Insulin pump settings during breastfeeding in women with type 1 diabetes.

No Effect of an Automated Bolus Calculator in Pediatric Patients with Type 1 Diabetes on Multiple Daily Injections: The Expert Kids Study.

Prospective analysis of the impact of commercialised hybrid closed-loop system on glycaemic control, glycaemic variability and patient-related outcomes in children and adults: a focus on superiority over predictive low glucose suspend technology.

Safety and Effectiveness of an Investigational Insulin Delivery Device Providing Basal/Bolus Therapy with Rapid-Acting or Regular Human Insulin in Adults with Type 2 Diabetes

Self-monitoring of Blood Glucose Requirements with the Use of Intermittently Scanned Continuous Glucose Monitoring.

The beneficial effect of the mobile application Euglyca® in Children and Adolescents with Diabetes Mellitus Type 1. A randomized controlled trial.

Development and psychometric validation of the novel Glucose Monitoring Experiences Questionnaire (GME-Q) among adults with type 1 diabetes.

Cost of Treating Skin Problems in Patients with Diabetes who Use Insulin Pumps and/or Glucose Sensors.

Feasibility of blood glucose management using intra-arterial glucose monitoring in combination with an automated insulin titration algorithm in critically ill patients.

Reversal of Ketosis in Type 1 Diabetes Is Not Adversely Affected by SGLT2 Inhibitor Therapy.